Table 1 Demographic characteristics of training cohort participants
Parameters | Healthy controls | Benign patients | BC patients | P value |
|---|---|---|---|---|
Number of samples | 20 | 30 | 75 | |
Age (years, mean ± SD) | 44.68 ± 13.20 | 43.60 ± 11.93 | 52.03 ± 10.62 | 0.001 |
Gender (female) | 20 | 30 | 75 | - |
BMI (mean±SD, kg/m2) | 22.47 ± 2.81 | 22.49 ± 2.29 | 23.02 ± 3.28 | 0.634 |
Tumor molecular type | NA | NA | - | |
Luminal A | 19 (25.3%) | |||
Luminal B | 34 (45.3%) | |||
HER-2+ | 14 (18.7%) | |||
Basal-like | 8 (10.7%) | |||
Menopause | 0.435 | |||
Post-menopausal women | 7 (35%) | 8 (26.7%) | 30 (40%) | |
Pre-menopausal women | 13 (65%) | 22 (73.3%) | 45 (60%) | |
Tumor stage | NA | NA | - | |
I | 31 (41.33%) | |||
II | 33 (44%) | |||
III | 11 (14.67%) |